37 min listen
A Potential Covid Breakthrough; CNBC Disruptors: Stripe CEO
FromSquawk Pod
ratings:
Length:
31 minutes
Released:
Jun 16, 2020
Format:
Podcast episode
Description
An Oxford University trial revealed that Dexamethasone, a common and inexpensive steroid, has been shown to improve survival rates in some Covid-19 patients. CNBC’s Meg Tirrell and Former FDA Commissioner Dr. Scott Gottlieb discuss the significance of this finding and its impact on health workers, global hope, and U.S. markets. CNBC has unveiled its annual list of Disruptors, a group of 50 up-and-coming companies disrupting industries and legacy brands. Number one on the list: payment platform Stripe. CEO John Collison shares how his platform’s been helping businesses stay afloat throughout the pandemic, and how he plans to keep his own business growing.
Released:
Jun 16, 2020
Format:
Podcast episode
Titles in the series (100)
Paul Tudor Jones: America’s Love of Freedom, Its Greatest Strength & Greatest Weakness: Hedge fund titan and Robin Hood founder Paul Tudor Jones weighs in on the markets, the American spirit, and charity amid the pandemic. Tonight’s Robin Hood Foundation Annual Benefit will be hosted virtually by Tina Fey. Dr. Scott Gottlieb explains the recently approved antigen test that identifies asymptomatic Covid carriers. PayPal CEO Dan Schulman shares how his platform is monitoring and accommodating shifting consumer behavior during the pandemic. Plus, Elon Musk’s busy weekend: filing a lawsuit against a California county and celebrating his partner Grimes’ first Mother’s Day with X Æ A-12. by Squawk Pod